P. Vestergaard

First name
P.
Last name
Vestergaard
Rasmussen, N. H., Driessen, J. H. M., Kvist, A. V., Souverein, P. C., van den Bergh, J. P., & Vestergaard, P. (2023). Fracture patterns and associated risk factors in pediatric and early adulthood type 1 diabetes: Findings from a nationwide retrospective cohort study. Bone, 180, 116997. http://doi.org/10.1016/j.bone.2023.116997
View
van Hulten, V., Driessen, J. H. M., Starup-Linde, J. K., Al-Mashhadi, Z. K., Viggers, R., Klungel, O. H., et al. (2023). The associations of sodium-glucose cotransporter-2 inhibitors versus dipeptidyl peptidase-4 inhibitors as add-on to metformin with fracture risk in patients with type 2 diabetes mellitus. Diabetes Obes Metab. http://doi.org/10.1111/dom.15220
View
Sarodnik, C., Rasmussen, N. H., Bours, S. P. G., Schaper, N. C., Vestergaard, P., Souverein, P. C., et al. (2022). The incidence of fractures at various sites in newly treated patients with type 2 diabetes mellitus. Bone Rep, 17, 101614. http://doi.org/10.1016/j.bonr.2022.101614
View
Bazelier, M. T., Van Staa, T., Uitdehaag, B. M., Cooper, C., Leufkens, H. G., Vestergaard, P., et al. (2011). The risk of fracture in patients with multiple sclerosis: the UK general practice research database. J Bone Miner Res. http://doi.org/10.1002/jbmr.418
View
Bazelier, M. T., van Staa, T. P., Uitdehaag, B. M., Cooper, C., Leufkens, H. G., Vestergaard, P., et al. (2012). A simple score for estimating the long-term risk of fracture in patients with multiple sclerosis. Neurology. http://doi.org/10.1212/WNL.0b013e318266faae
View
Bazelier, M. T., de Vries, F., Vestergaard, P., Herings, R. M., Gallagher, A. M., Leufkens, H. G., & van Staa, T. P. (2013). Risk of fracture with thiazolidinediones: an individual patient data meta-analysis. Front Endocrinol (Lausanne). http://doi.org/10.3389/fendo.2013.00011
View
Dhiman, P., Andersen, S., Vestergaard, P., Masud, T., & Qureshi, N. (2018). Does bone mineral density improve the predictive accuracy of fracture risk assessment? A prospective cohort study in Northern Denmark. BMJ Open. http://doi.org/10.1136/bmjopen-2017-018898
View
Werkman, N. C. C., Nielen, J. T. H., van den Bergh, J. P. W., Ejskjaer, N., R\oikjer, J., Schaper, N. C., et al. (2020). Use of Sodium-Glucose Co-Transporter-2-Inhibitors (SGLT2-Is) and Risk of Lower Limb Amputation. Curr Drug Saf. http://doi.org/10.2174/1574886315666200805103053
View
Rasmussen, N. H., Sarodnik, C., Bours, S. P. G., Schaper, N. C., Souverein, P. C., Jensen, M. H., et al. (2021). The pattern of incident fractures according to fracture site in people with T1D. Osteoporos Int. http://doi.org/10.1007/s00198-021-06175-z
View
R\oikjer, J., Werkman, N. C. C., Ejskjaer, N., van den Bergh, J. P. W., Vestergaard, P., Schaper, N. C., et al. (2021). Incidence, hospitalization and mortality and their changes over time in people with a first ever diabetic foot ulcer. Diabet Med. http://doi.org/10.1111/dme.14725
View